Apheresis is an invasive process that involves the separation of components such as platelets, RBC, plasma, and other components from whole blood. In this procedure, the blood of a donor or a patient is passed through an apheresis machine or a blood cell separator. The apheresis equipment spins the blood to separate the required component from other blood components. A selected part of the blood is removed, and the remaining elements are returned to the donor or the patient. It involves the use of devices and disposables along with separation technologies such as centrifugation and membrane filtration. The equipment used in apheresis include manual and automated systems.
Technavio's analysts forecast the global apheresis equipment market to grow at a CAGR of 10.72% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global apheresis equipment market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various devices and disposables used in apheresis that are available in the market. The two major technologies discussed in the report are centrifugation and membrane filtration.
Technavio's report, Global Apheresis Equipment Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also covers the landscape of the global apheresis equipment market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Technavio Announces the Publication of its Research Report – Global Apheresis Equipment Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Apheresis Equipment Market: Terumo BCT, Haemonetics, Fenwal, Asahi Kasei Medical and Macopharma
Other Prominent Vendors in the market are: Cerus, HemaCare, Kawasumi Laboratories, Therakos, Grifols, Hemagen Diagnostics, and Immucor.
Commenting on the report, an analyst from Technavio’s team said: “National blood banks, hospitals, and non-profit organizations are undergoing collaborations to boost their operational efficiency. For instance, member physicians of the Blood Services Group organize regular meetings and seminars for clinicians of various hospitals. An efficient national blood system requires collaboration and coordination among government ministries, laboratories, blood banks, institutions for public health, non-profit organizations, and hospitals.”
According to the report, the incidence of hematological disorders, such as severe leukemia, anemia, and sickle cell disease, has increased worldwide over the past few years. Physicians use apheresis to collect plasma, platelets, white blood cells, red blood cells, and other blood components for treating hematological disorders.
Further, the report states that the World Apheresis Association reported that the frequency of adverse reactions due to apheresis is less than those caused by the whole blood process. However, an adverse reaction due to apheresis is more likely to require hospitalization. Hypocalcemia is the most common complication of apheresis caused by citrate anticoagulation. This complication can cause hypoparathyroidism, acute pancreatitis, vitamin D deficiency, and chronic kidney diseases.
Terumo BCT, Haemonetics, Fenwal, Asahi Kasei Medical, Macopharma, Cerus, HemaCare, Kawasumi Laboratories, Therakos, Grifols, Hemagen Diagnostics, Immucor.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook